Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary malignant mediastinal tumors.

R B Adkins, M D Maples, J D Hainsworth

    The Annals of Thoracic Surgery
    |December 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Aggressive multidisciplinary treatment, including surgery, chemotherapy, and radiation, has improved survival rates for primary mediastinal tumors. Many of these rare cancers are now curable with combined therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2019
    Same author

    Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015
    Same author

    Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset.

    International journal of clinical oncology·2013
    Same author

    B cells in rheumatology--transforming thinking in rheumatoid arthritis.

    Rheumatology (Oxford, England)·2005

    Area of Science:

    • Oncology
    • Thoracic Surgery
    • Medical Oncology

    Background:

    • Primary mediastinal tumors encompass a diverse range of rare malignancies.
    • This review analyzes treatment outcomes for 38 patients with various mediastinal tumors diagnosed since 1970.

    Observation:

    • Germ cell tumors showed a mean survival of 3.3 years.
    • Mediastinal neuroblastomas in children had a high survival rate (6.7 years mean).
    • Lymphoproliferative disorders, including Hodgkin's disease, had a mean survival of 5.1 years.

    Findings:

    • Carcinomas and angiopericytomas had poor prognoses, with less than 2-year survival.
    • Thymomas averaged 3.7 years survival, while thymic carcinoids had less than 1-year survival.
    • Overall 5-year survival improved from 26% (pre-1970) to 47.3% (post-1970), with disease-free survival at 34.2%.

    Related Experiment Videos

    Implications:

    • Aggressive, combined-modality treatment is crucial for improving outcomes in primary mediastinal malignancies.
    • A multidisciplinary approach enhances the curability of these complex thoracic tumors.
    • Continued research and treatment refinement are vital for advancing the management of mediastinal cancers.